Post-travel acute febrile illness – dengue fever

Authors

  • Folasade Ijaola Russell’s Hall Hospital, Dudley, United Kingdom

DOI:

https://doi.org/10.51496/jogm.v3.109

Keywords:

Dengue Fever, Rickettsia, Post-travel febrile illness

References

Snowden J, Ladd M, King KC. Rickettsial infection. 2023. Treasure Island, FL: StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431127/ [cited 15 May 2023].

Donaldson CD, De Mel S, Clarice CSH, Thilakawardana BU, De Mel P, Shalindi M, et al. Admission ultrasonography as a predictive tool for thrombocytopenia and disease severity in dengue infection. Trans R Soc Trop Med Hyg 2021; 115(12): 1396–402. doi: 10.1093/trstmh/trab064 DOI: https://doi.org/10.1093/trstmh/trab064

Kularatne SA, Dalugama C. Dengue infection: global importance, immunopathology and management. Clin Med (London) 2022; 22(1): 9–13. doi: 10.7861/clinmed.2021-0791 DOI: https://doi.org/10.7861/clinmed.2021-0791

Kularatne SAM. Dengue fever. BMJ 2015; 351: h4661. doi: 10.1136/bmj.h4661 DOI: https://doi.org/10.1136/bmj.h4661

Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016; 2016: 6803098. doi: 10.1155/2016/6803098 DOI: https://doi.org/10.1155/2016/6803098

Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD). 14 Jul 2020. Available from: https://www.cdc.gov/dengue/symptoms/index.html [cited 15 May 2023].

World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue guidelines for diagnosis, treatment, prevention and control: new edition. WHO; 2009, pp. 25–7. Available from: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf?ua=1 [cited 19 May 2023]

European Medicines Agency (EMA). Dengvaxia EPAR product information. Amsterdam: EMA; 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/dengvaxia-epar-product-information_en.pdf [cited 19 May 2023].

European Medicines Agency (EMA). Qdenga EPAR product information. Amsterdam: EMA; 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/qdenga-epar-product-information_en.pdf [cited 19 May 2023].

European Centre for Disease Prevention and Control. Factsheet about Dengue. [updated 4 Mar 2021]. Available from: https://www.ecdu.europa.eu/en/dengue-fever/facts [cited 21 May 2023].

WHO. Dengue and severe dengue factsheet. [updated 10 Jan 2022]. Dengue and severe dengue (who.int). Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue [cited 6 June 2023].

European Centre for Disease Prevention and Control – EN – [PNG-457.86 KB]. Dengue worldwide overview (europa.eu). Available from: https://www.ecdc.europa.eu/en/dengue-monthly [cited 6 June 2023].

Travel-associated infections in England, Wales and Northern Ireland: 2020 and 2021. [Updated 7 Dec 2022]. Available from: https://www.gov.uk/government/publications/travel-associated-infections/travel-associated-infections-in-england-wales-and-northern-ireland-2020-and-2021 [cited 20 June 2023].

Published

19-09-2023

How to Cite

Ijaola, F. (2023). Post-travel acute febrile illness – dengue fever. Journal of Global Medicine, 3(1), e109. https://doi.org/10.51496/jogm.v3.109

Issue

Section

Clinical Scenarios

Categories